TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$1.58
-0.03 (-1.86%)
As of Nov 12, 4:21 PM ET ·
Financial Highlights (FY 2026)
Revenue
10.0K
Net Income
-8,259,936
Gross Margin
—
Profit Margin
-83,520.0%
Rev Growth
-88.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 33.9% 33.9%
Operating Margin -84,500.0% -76,050.8% -6.9% -6.6%
Profit Margin -83,520.0% -79,344.0% -6.2% -6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 10.0K 83.8K 1.35M 1.27M
Gross Profit — — 457.7K 431.9K
Operating Income -8,466,055 -63,707,771 -93,195 -83,844
Net Income -8,259,936 -62,156,709 -84,207 -82,182
Gross Margin — — 33.9% 33.9%
Operating Margin -84,500.0% -76,050.8% -6.9% -6.6%
Profit Margin -83,520.0% -79,344.0% -6.2% -6.5%
Rev Growth -88.0% -88.0% +20.4% +2.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.88M 2.33M
Total Equity — — 1.84M 1.81M
D/E Ratio — — 1.56 1.28
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,343,179 -66,271,070 -111,401 -119,566
Free Cash Flow — — -113,905 -126,135